119 related articles for article (PubMed ID: 18193073)
1. Cardiovascular reactivity after blockade of angiotensin AT1 receptors in the experimental model of tilting test in conscious rats.
Bedette D; Santos RA; Fontes MA
Br J Pharmacol; 2008 Mar; 153(5):966-71. PubMed ID: 18193073
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats.
de Moura MM; dos Santos RA; Fontes MA
Br J Pharmacol; 2005 Mar; 144(6):755-60. PubMed ID: 15685215
[TBL] [Abstract][Full Text] [Related]
3. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
Liang B; Leenen FH
J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats.
Dai Q; Xu M; Yao M; Sun B
Br J Pharmacol; 2007 Dec; 152(7):1042-8. PubMed ID: 17922026
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
Toba H; Wang J; Ohigashi M; Kobara M; Nakata T
Pharmacology; 2013; 92(5-6):265-75. PubMed ID: 24281041
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock.
Łukawski K; Janowska A; Jakubus T; Tochman-Gawda A; Czuczwar SJ
Eur J Pharmacol; 2010 Aug; 640(1-3):172-7. PubMed ID: 20465998
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive effect of angiotensin II after AT1-receptor blockade with losartan.
Matys T; Pawlak R; Kucharewicz I; Chabielska E; Buczko W
J Physiol Pharmacol; 2000 Mar; 51(1):161-6. PubMed ID: 10768859
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats.
van Meel JC; Redemann N; Haigh RM
Arzneimittelforschung; 1996 Aug; 46(8):755-9. PubMed ID: 9125273
[TBL] [Abstract][Full Text] [Related]
10. Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats.
Collister JP; Nahey DB
J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):10-6. PubMed ID: 18404603
[TBL] [Abstract][Full Text] [Related]
11. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA
J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
Toba H; Tojo C; Wang J; Noda K; Kobara M; Nakata T
Eur J Pharmacol; 2012 Jun; 685(1-3):91-8. PubMed ID: 22314223
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
14. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
15. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
[TBL] [Abstract][Full Text] [Related]
16. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T
J Pharmacol Exp Ther; 2001 Jul; 298(1):62-70. PubMed ID: 11408526
[TBL] [Abstract][Full Text] [Related]
17. Effect of Combined Treatment with AT1 Receptor Antagonists and Tiagabine on Seizures, Memory and Motor Coordination in Mice.
Łukawski K; Janowska A; Czuczwar SJ
Adv Clin Exp Med; 2015; 24(4):565-70. PubMed ID: 26469099
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
Kakuta H; Sudoh K; Sasamata M; Yamagishi S
Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
[TBL] [Abstract][Full Text] [Related]
19. Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the post-infarct state.
Cudnoch-Jedrzejewska A; Dobruch J; Puchalska L; Szczepańska-Sadowska E
Regul Pept; 2007 Aug; 142(3):86-94. PubMed ID: 17350115
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]